Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Introducton
4.2 Drivers
4.2.1 Rising prevalence of chronic respiratory disease
4.2.2 Increasing usage of combination therapy
4.2.3 Growing need for rescue medication
4.2.4 Technological advancements
4.3 Restraints
4.3.1 No single, effective device for every respiratory disorders
4.3.2 Side effects and complications during inhalation
4.3.3 High price
4.3.4 Non-standardized dosage
4.4 Opportunities
4.4.1 Advanced products
4.4.2 Increasing demand in developing countries
4.5 Challenges
4.5.1 Strong competition
4.5.2 More advanced products
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
6 Global Respiratory Inhalers Market, By Type
6.1 Introduction
6.2 Manually Operated Inhaler
6.3 Digitally Operated Inhaler
7 Global Respiratory Inhalers Market, By Product
7.1 Introduction
7.2 Dry Powder Inhaler
7.3 Metered Dose Inhaler
8 Global Respiratory Inhalers Market, By Application
8.1 Introduction
8.2 Asthma
8.3 COPD
9 Global Respiratory Inhalers Market, By End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Respiratory Care Centers
10 Global Respiratory Inhalers Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Western Europe
10.3.7 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Republic of Korea
10.4.5 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Company Share Analysis
12 Company Profiles
12.1 Adherium
12.1.1 Company Overview
12.1.2 Product/Business Overview
12.1.3 Adherium Health: Financials
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.2 AstraZeneca
12.2.1 Company Overview
12.2.2 Product overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Boehringer Ingelheim GmbH
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Chiesi Farmaceutici S.p.A.
12.4.1 Company Overview
12.4.2 Product Overview
12.4.3 Financial Overview
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.5 GlaxoSmithKline
12.5.1 Company Overview
12.5.2 Product overview
12.5.3 Financial Overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Propeller Health
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Propeller Health: Financials
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Teva Pharmaceutical Industries Ltd
12.7.1 Company Overview
12.7.2 Product Overview
12.7.3 Financial Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis